ibuprofen has been researched along with Supranuclear Palsy, Progressive in 1 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
Supranuclear Palsy, Progressive: A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marras, C | 1 |
Cunningham, CR | 1 |
Hou, J | 1 |
Proudfoot, J | 1 |
Standaert, DG | 1 |
Juncos, J | 1 |
Riley, D | 1 |
Reich, SG | 1 |
Hall, D | 1 |
Kluger, B | 1 |
Bordelon, Y | 1 |
Shprecher, DR | 1 |
Litvan, I | 1 |
1 other study available for ibuprofen and Supranuclear Palsy, Progressive
Article | Year |
---|---|
Anti-inflammatory drug use and progressive supranuclear palsy.
Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Female; Humans; Ib | 2018 |